Updates

Explore Medicines360’s latest news and resources

Press Releases

In the Wake of Supreme Court Decision, Medicines360 Stands With Women

Nonprofit women’s health pharmaceutical organization affirms commitment to expand access to birth control in U.S San Francisco, CA – Today, following the Supreme Court’s release of the majority decision in  Dobbs v. Jackson Women’s Health Organization, Medicines360 CEO Tina Raine-Bennett, MD, MPH, released the following statement: “At Medicines360, our work is driven by our deep […]

Read More >
Press Releases

Medicines360 Applauds HELP Committee for Including Critical Amendments on Nonprofit Pharma in Legislation Headed to Senate Floor  

Committee member Senator Rosen has been a leading voice supporting the nonprofit pharmaceutical model San Francisco, CA –  Earlier this week, the United States Senate Health, Education, Labor, and Pensions (HELP) Committee advanced the Food and Drug Administration Safety and Landmark Advancements (FDASLA Act/ S. 4348) Act to the full Senate floor with broad bipartisan […]

Read More >
Press Releases

Medicines360 Applauds Sens. Rosen and Romney for Introducing Critical Legislation to Explore Benefits of Nonprofit Pharmaceutical Model 

Senator Rosen has been a leading voice supporting the nonprofit pharmaceutical model  San Francisco, CA –  Last week, U.S. Senators Jacky Rosen (D-NV) and Mitt Romney (R-UT), announced the introduction of the Advancing Affordable Medicines for Families Act (S. 4341), bipartisan legislation which would direct the Government Accountability Office (GAO) to conduct a report on […]

Read More >
Press Releases

Medicines360 Appoints Elizabeth Garner, M.D., M.P.H. to Board of Directors 

SAN FRANCISCO – May 12, 2022 – Medicines360, the mission-driven nonprofit women’s health pharmaceutical organization, has appointed Elizabeth Garner MD, MPH, as a member of its Board of Directors, effective immediately. With over a decade of pharmaceutical development experience, Dr. Garner brings expansive knowledge in regulatory and clinical affairs, and a deep commitment to increasing […]

Read More >
Press Releases

Medicines360, Population Services International, and Society for Family Health Announce Launch of Avibela® Hormonal Intrauterine Device in Nigeria

Improving Access to Modern Contraception for Women in Nigeria  SAN FRANCISCO, WASHINGTON and ABUJA– March 22, 2022– Medicines360, Population Services International (PSI), and Society for Family Health (SFH) announced the launch of Avibela (levonorgestrel-releasing intrauterine system) 52 mg in Nigeria. Nigerian women and girls’ contraceptive options have historically been limited. The introduction of Avibela provides […]

Read More >
Press Releases

Medicines360 Announces Price Subsidy of its Hormonal IUD Avibela to Expand Access to Contraception

In August 2021 – Medicines360, the mission-driven nonprofit Women’s Health pharmaceutical organization announced a price subsidy to expand contraceptive access for millions of women in some of the world’s poorest countries. When purchased from its subsidiary, Impact RH360, Avibela will be offered at the price of $9.50 through international procurement groups. “We believe that women […]

Read More >